Literature DB >> 2141311

Current views on the aetiology, pathogenesis and treatment of acne vulgaris.

L Lever1, R Marks.   

Abstract

Acne may vary from a relatively trivial condition to a severe disfiguring disease and management must be tailored to suit individuals. Pathogenetic factors that may be addressed by treatment include increased sebum secretion, abnormal follicular keratinisation, bacterial colonisation and local inflammation. Mild acne can be controlled with topical preparations alone but many patients with more severe disease require oral therapy with antibiotics, antiandrogens or retinoids. Combinations of topical and systemic treatments are often appropriate. The choice of drug requires knowledge of their efficacy, ease of use and possible adverse effects.

Entities:  

Mesh:

Year:  1990        PMID: 2141311     DOI: 10.2165/00003495-199039050-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  86 in total

1.  Spironolactone and cimetidine in treatment of acne.

Authors:  A Hatwal; R P Bhatt; J K Agrawal; G Singh; H S Bajpai
Journal:  Acta Derm Venereol       Date:  1988       Impact factor: 4.437

2.  Tolerance of spironolactone.

Authors:  B R Hughes; W J Cunliffe
Journal:  Br J Dermatol       Date:  1988-05       Impact factor: 9.302

Review 3.  Recent advances in hormonal aspects of acne vulgaris.

Authors:  C R Darley
Journal:  Int J Dermatol       Date:  1984-10       Impact factor: 2.736

Review 4.  Current concepts: topical therapy for acne.

Authors:  J W Melski; K A Arndt
Journal:  N Engl J Med       Date:  1980-02-28       Impact factor: 91.245

5.  Induction of colitis in hamsters by topical application of antibiotics.

Authors:  D S Feingold; W C Chen; D L Chou; T W Chang
Journal:  Arch Dermatol       Date:  1979-05

6.  Oral spironolactone improves acne vulgaris and reduces sebum excretion.

Authors:  A Goodfellow; J Alaghband-Zadeh; G Carter; J J Cream; S Holland; J Scully; P Wise
Journal:  Br J Dermatol       Date:  1984-08       Impact factor: 9.302

7.  Skin surface lipid composition, acne, pubertal development, and urinary excretion of testosterone and 17-ketosteroids in children.

Authors:  P E Pochi; J S Strauss; D T Downing
Journal:  J Invest Dermatol       Date:  1977-11       Impact factor: 8.551

8.  A double-blind, comparative study of benzoyl peroxide, benzoyl peroxide-chlorhydroxyquinoline, benzoyl peroxide-chlorhydroxyquinoline-hydrocortisone, and placebo lotions in acne.

Authors:  M Ede
Journal:  Curr Ther Res Clin Exp       Date:  1973-09

9.  Minocycline treatment of tetracycline-resistant and tetracycline-responsive acne vulgaris.

Authors:  R E Rossman
Journal:  Cutis       Date:  1981-02

10.  Benzoyl peroxide: lack of sensitization.

Authors:  W J Cunliffe; B Burke
Journal:  Acta Derm Venereol       Date:  1982       Impact factor: 4.437

View more
  3 in total

1.  Penetration of tinidazole into skin blister fluid following its oral administration.

Authors:  A Klimowicz; A Nowak; S Bielecka-Grzela
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  [Acne vulgaris].

Authors:  M Toscano; J Tousignant; G Panet-Raymond
Journal:  Can Fam Physician       Date:  1992-11       Impact factor: 3.275

Review 3.  Drospirenone/ethinylestradiol 3mg/20microg (24/4 day regimen): a review of its use in contraception, premenstrual dysphoric disorder and moderate acne vulgaris.

Authors:  Caroline Fenton; Keri Wellington; Marit D Moen; Dean M Robinson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.